<DOC>
	<DOCNO>NCT00220220</DOCNO>
	<brief_summary>Test efficacy safety combination olmesartan amlodipine hypertensive patient whose blood pressure adequately control olmesartan alone .</brief_summary>
	<brief_title>Amlodipine Add-on Olmesartan Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Mean sit BP great equal 140/90115 mmHg mean 24h dBP great equal 80 mmHg least 30 % daytime reading great 85 mmHg prior randomization . Secondary hypertension aetiology ; Any serious disorder may limit ability evaluate efficacy safety test drug ( ) ; History myocardial infarction , unstable angina pectoris , percutaneous coronary intervention , congestive heart failure , hypertensive encephalopathy , stroke TIA within last 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>